Neil Graham

Neil Graham

Director/Board Member at ASLAN PHARMACEUTICALS LIMITED

Net worth: - $ as of 31/05/2026

67 year
Health Technology
Consumer Services
Technology Services

Profile

Neil Graham is currently an Independent Non-Executive Director at Aslan Pharmaceuticals Ltd. since 2021.
Former roles include Independent Non-Executive Director at Syntara Ltd. from 2020 to 2023, Independent Director at Allakos, Inc. from 2023 to 2025, Independent Non-Executive Director at Zura Bio Ltd. from 2023 to 2026, VP-Strategic Program Direction & Immunology at Regeneron Pharmaceuticals, Inc. from 2009 to 2020, SVP-Program & Portfolio Management at Trimeris, Inc. from 2005 to 2007, Chief Medical Officer & VP-Clinical Development at XTL Biopharmaceuticals Ltd. from 2002 to 2005, Senior Vice President-Program & Portfolio at Vertex, Inc. from 2007 to 2009, Associate Professor at Johns Hopkins Bloomberg School of Public Health from 1989 to 1997, Chief Medical Officer at Tiziana Life Sciences Ltd. (United Kingdom) from 2021 to 2022, Director-HIV Medical Affairs at Glaxo Wellcome Plc, Independent Director at ASLAN Pharmaceuticals Pte Ltd., and Chief Development Officer at Evelo Biosciences, Inc. Education includes a doctorate from the University of Adelaide.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
21/05/2025 0 ( -.--% ) - $ 31/05/2026

Neil Graham active positions

CompaniesPositionStart
ASLAN PHARMACEUTICALS LIMITED Director/Board Member 18/02/2021

Former positions of Neil Graham

CompaniesPositionEnd
ZURA BIO LIMITED Director/Board Member 21/02/2026
ALLAKOS INC. Director/Board Member 15/05/2025
Director/Board Member 17/07/2024
SYNTARA LIMITED Director/Board Member 03/10/2023
Chief Tech/Sci/R&D Officer 18/07/2022
See the detail of Neil Graham's experience

Training of Neil Graham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!